In 1934, a Senate committee opened hearings its chairman said would show that America’s involvement in WWI was “not a matter of national honor and national defense, but a matter of profit for the few.” Ninety-three hearings and 200 witnesses, however, did little to support that claim. Rather the hearings drew increased attention to arms manufacturers as “merchants of death” and inspired Congress to pass three neutrality acts that signaled “profound American opposition to overseas involvement” in the years preceding America’s entry into WWII.1

A new Mayo Clinic study finds that not all women with lymph node-positive breast cancer treated with chemotherapy before surgery need to have all of their underarm nodes taken out. Ultrasound is a useful tool for judging before breast cancer surgery whether chemotherapy eliminated cancer from the underarm lymph nodes, the researchers found. The findings are published in the Journal of Clinical Oncology.

Radiologists at the prestigious Dana-Farber Cancer Institute (Boston, Mass.) are using Carestream’s lesion management module with Carestream Vue PACS to capture information about tumors and how they respond to treatment.

February 4, 2015 — Lantheus Medical Imaging Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA) allowing Jubilant HollisterStier (JHS) to be a new manufacturer for its proprietary brain perfusion imaging agent Neurolite.

information technology, PACS, cardiac PACS, Roadmap Version 1.0

The Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology (ONC) released Connecting Health and Care for the Nation: A Shared Nationwide Interoperability Roadmap Version 1.0. 

Intelerad Medical Systems has been awarded a five-year, Schedule 70 contract with the U.S. General Services Administration (GSA).

Elekta's Mosaiq Oncology Information System (OIS) has earned the number one ranking among OISs, according to a survey by KLAS, an independent research firm.

Carestream Health was awarded 66 new patents from the U.S. Patent and Trademark Office in 2014 for innovations in radiology imaging, healthcare information technology (IT), dental imaging and other areas. The company also received 34 additional patents in European and Asian countries last year.

Scientists are working to develop breakthrough therapies for pancreatic cancer, one of the deadliest cancers affecting both men and women.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now